8 reports

  • 2.3 Global IVD Market Value by Technology

To support the partnership, the Abbott Fund is providing US$## million funds over three years.

  • In Vitro Diagnostics
  • Point Of Care Testing
  • World
  • Market Size
  • Thermo Fisher Scientific, Inc.
  • 2.5 Global IVD Market by Technology

Global In- Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook (2018-2022) ##.

  • Leukemia
  • Medical Device
  • Point Of Care Testing
  • World
  • Market Size
  • 2.5 Global IVD Market by Technology

Global In- Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook (2018-2022) ##.

  • Leukemia
  • Medical Device
  • Point Of Care Testing
  • World
  • Market Size
  • Products under Development

The FACT ## trial is evaluating the safety and efficacy of Genentech s drugs, Herceptinand Perjeta, and chemotherapy, in early stage breast cancer patients selected with Celcuity s CELx HSF Test.

  • Clinical Trial
  • Diagnostics
  • Leukemia
  • Point Of Care Testing
  • Grifols, S.A.

The company offers a wide range of drugs including drugs for pain, inflammation, and allergies; drugs for urological diseases; drugs for hematologic malignancies; drugs for gastrointestinal disorders; drugs for cardiovascular and metabol

  • Leukemia
  • Pathology
  • Therapy
  • United States
  • Product Initiative

You can easily book an appointment with one online.

  • Leukemia
  • Point Of Care Testing
  • Becton Property Group
  • Millipore Corporation
  • Thermo Fisher Scientific, Inc.

The company offers a wide range of drugs including drugs for pain, inflammation, and allergies; drugs for urological diseases; drugs for hematologic malignancies; drugs for gastrointestinal disorders; drugs for cardiovascular and metabol

  • Leukemia
  • Therapy
  • United States
  • Company Operations
  • Product Initiative

R& D Progress Research and Development Brief SMALL MOLECULE TO INHIBIT IGE FOR ALLERGIES Product Description IgE inhibitor is under development of the treatment of allergy.

  • Leukemia
  • Research And Development
  • Japan
  • Company Operations
  • Interprotein Corporation